{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:33:14Z","timestamp":1758706394086},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.humimm.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T18:37:11Z","timestamp":1337279831000},"page":"783-787","source":"Crossref","is-referenced-by-count":6,"title":["In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection"],"prefix":"10.1016","volume":"73","author":[{"given":"Geraldine M.","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafisa-Katrin","family":"Seich Al Basatena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Olavarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"MacNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Vine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michie","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Galv\u00e3o-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becca","family":"Asquith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"McVicar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2012.05.006_b0005","first-page":"205","article-title":"The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown","volume":"11","author":"Hlela","year":"2009","journal-title":"AIDS Rev"},{"key":"10.1016\/j.humimm.2012.05.006_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12185-011-0934-4","article-title":"Current status of HTLV-1 infection","volume":"94","author":"Watanabe","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humimm.2012.05.006_b0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.humimm.2012.05.006_b0020","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humimm.2012.05.006_b0030","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","article-title":"Human T-lymphotropic virus type I infection","volume":"353","author":"Manns","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2012.05.006_b0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1016\/j.humimm.2012.05.006_b0040","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","article-title":"Cellular immune response to HTLV-1","volume":"24","author":"Bangham","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humimm.2012.05.006_b0045","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","article-title":"The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection","volume":"165","author":"Jeffery","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.05.006_b0050","doi-asserted-by":"crossref","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"Macnamara","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.humimm.2012.05.006_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1744-313X.2007.00739.x","article-title":"Killer cell immunoglobulin-like receptors on NK cells: the how, where and why","volume":"35","author":"Gardiner","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.humimm.2012.05.006_b0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.smim.2008.10.002","article-title":"The genetic and evolutionary balances in human NK cell receptor diversity","volume":"20","author":"Parham","year":"2008","journal-title":"Semin Immunol"},{"key":"10.1016\/j.humimm.2012.05.006_b0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.humimm.2012.05.006_b0070","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JVI.00256-09","article-title":"HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection","volume":"83","author":"Alter","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2012.05.006_b0075","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1084\/jem.20070695","article-title":"Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR\/HLA subtypes","volume":"204","author":"Alter","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2012.05.006_b0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.178.1.235","article-title":"Functional polymorphism of the KIR3DL1\/S1 receptor on human NK cells","volume":"178","author":"O\u2019Connor","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.05.006_b0085","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.178.2.647","article-title":"Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation","volume":"178","author":"Carr","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.05.006_b0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/aid.2006.0165","article-title":"Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes","volume":"23","author":"Gillespie","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.humimm.2012.05.006_b0095","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.22767","article-title":"Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types","volume":"121","author":"Goedert","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humimm.2012.05.006_b0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1537-2995.1997.37297203532.x","article-title":"Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study","volume":"37","author":"Galvao-Castro","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2012.05.006_b0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200312150-00013","article-title":"HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics","volume":"34","author":"Dourado","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.humimm.2012.05.006_b0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM)","volume":"22","author":"De Castro-Costa","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.humimm.2012.05.006_b0115","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humimm.2012.05.006_b0120","unstructured":"Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP. In: Blattner WA, editor. Human, retrovirology. New York: Raven Press; 1990. p. 191\u20137."},{"key":"10.1016\/j.humimm.2012.05.006_b0125","unstructured":"John Hansen E. Joint report: 13th IHWS, Section A5: Sequence based HLA typing. In: Proceedings of the 13th international histocompatibility workshop and conference, vol. 1. Seattle, Washington; 2002. p. 304\u2013416."},{"key":"10.1016\/j.humimm.2012.05.006_b0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-60761-362-6_25","article-title":"KIR genotyping by multiplex PCR-SSP","volume":"612","author":"Kulkarni","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humimm.2012.05.006_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(01)00445-1","article-title":"Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay","volume":"102","author":"Dehee","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/j.humimm.2012.05.006_b0140","first-page":"409","article-title":"Growth and manipulation of a human T-cell leukemia virus type 2 full-length molecular clone","volume":"304","author":"Anderson","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humimm.2012.05.006_b0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jviromet.2003.11.016","article-title":"Transformation studies with a human T-cell leukemia virus type 1 molecular clone","volume":"116","author":"Anderson","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.humimm.2012.05.006_b0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.meegid.2005.02.001","article-title":"On the phylogenetic placement of human T cell leukemia virus type 1 sequences associated with an Andean mummy","volume":"6","author":"Coulthart","year":"2006","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.humimm.2012.05.006_b0155","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/71006","article-title":"The presence of ancient human T-cell lymphotropic virus type I provirus DNA in an Andean mummy","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2012.05.006_b0160","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ng2111","article-title":"Unusual selection on the KIR3DL1\/S1 natural killer cell receptor in Africans","volume":"39","author":"Norman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.humimm.2012.05.006_b0165","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.humimm.2010.05.011","article-title":"Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy\/tropical spastic paraparesis in Peru","volume":"71","author":"Talledo","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2012.05.006_b0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","article-title":"Neuroimmunity of HTLV-I Infection","volume":"5","author":"Matsuura","year":"2010","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T17:27:00Z","timestamp":1561742820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885912001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0198885912001206"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2012.05.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}